Recent News

• 06.05.2025 - Jefferies Global Healthcare Conference
• 06.05.2025 - Jefferies Global Healthcare Conference
• 05.28.2025 - Ventyx Biosciences to Participate in the Jefferies Global Healthcare Conference
• 05.28.2025 - Ventyx Biosciences to Participate in the Jefferies Global Healthcare Conference
• 05.08.2025 - Ventyx Biosciences Reports First Quarter 2025 Financial Results and Highlights Recent Corporate Progress
• 05.08.2025 - Ventyx Biosciences Reports First Quarter 2025 Financial Results and Highlights Recent Corporate Progress
• 04.01.2025 - Ventyx Biosciences Expands SAB with Renowned NLRP3 Experts and Prominent Neurodegenerative and Cardiometabolic Disease Specialists
• 04.01.2025 - Ventyx Biosciences Expands SAB with Renowned NLRP3 Experts and Prominent Neurodegenerative and Cardiometabolic Disease Specialists

Recent Filings

• 05.16.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.16.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.15.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.15.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.08.2025 - 8-K Current report
• 05.08.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.08.2025 - EX-99.1 EX-99.1
• 04.23.2025 - ARS Annual Report to Security Holders
• 04.23.2025 - DEF 14A Other definitive proxy statements
• 04.23.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material